Skip to content

13F-HR filed by Darwin Global Management, Ltd.

Darwin Global Management, Ltd. filed this 13F-HR for the quarter ended 2021-06-30, filed 2021-08-16, with 12 holding rows worth $619,934,000.

Accession
0001420506-21-001288
Filed
2021-08-16
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2021

A holdings report, 12 entries on the cover page, a total value of $619,934,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $619,934,000 with VALUE read as thousands by filing date, 13F file number 028-21006. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
INTELLIA THERAPEUTICS INC45826J105COM1,859,926$301,141,000thousands by filing date
ACCELERON PHARMA INC00434H108COM1,760,346$220,906,000thousands by filing date
FATE THERAPEUTICS INC31189P102COM335,918$29,154,000thousands by filing date
BRIDGEBIO PHARMA INC10806X102COM336,817$20,532,000thousands by filing date
BEAM THERAPEUTICS INC07373V105COM126,985$16,344,000thousands by filing date
VERVE THERAPEUTICS INC92539P101COM103,013$6,207,000thousands by filing date
INHIBRX INC45720L107COM225,480$6,205,000thousands by filing date
ESSA PHARMA INC29668H708COM NEW208,524$5,958,000thousands by filing date
KEROS THERAPEUTICS INC COM492327101Stock104,186$4,425,000thousands by filing date
ACLARIS THERAPEUTICS INC COM00461U105Stock250,000$4,390,000thousands by filing date
RELAY THERAPEUTICS INC COM75943R102Stock119,775$4,383,000thousands by filing date
GENERATION BIO CO37148K100COM10,738$289,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001420506-21-001288this filing2021-08-16acceptance time not in the bulk data set